CASIF · CASI Pharmaceuticals, Inc.
Market Cap
$2.67M
Shares
20.56M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-14 | — | |
| 6-K | 2026-08-13 | — | |
| 6-K | 2026-07-15 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-02 | — | |
| 20-F | 2026-05-15 | 2025-12-31 | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-15 | — | |
| 6-K | 2026-03-03 | — | |
| 6-K | 2026-02-25 | — | |
| 6-K | 2026-02-20 | — | |
| 6-K | 2026-02-19 | — | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-01-22 | — | |
| 6-K | 2026-01-13 | — | |
| 6-K | 2025-12-31 | 2025-12-30 | |
| 6-K | 2025-12-23 | — | |
| 6-K | 2025-12-11 | — | |
| 6-K | 2025-11-19 | — | |
| 6-K | 2025-11-14 | — | |
| 6-K | 2025-11-10 | — | |
| 6-K | 2025-09-26 | — | |
| 6-K | 2025-09-02 | — | |
| 6-K | 2025-08-29 | — | |
| 6-K | 2025-08-27 | — | |
| 6-K | 2025-08-04 | — | |
| 6-K | 2025-07-22 | 2025-07-21 | |
| 6-K | 2025-05-20 | — | |
| 6-K/A | 2025-05-20 | — | |
| 6-K | 2025-05-16 | — | |
| 6-K | 2025-05-14 | — | |
| 6-K | 2025-05-12 | — | |
| 6-K | 2025-05-07 | — | |
| 6-K | 2025-04-09 | — | |
| 6-K | 2025-04-03 | — | |
| 6-K | 2025-04-03 | — | |
| 20-F | 2025-03-31 | 2024-12-31 | |
| 6-K | 2025-03-31 | — | |
| 6-K | 2025-02-10 | — | |
| 6-K | 2025-01-21 | — | |
| 6-K | 2024-12-26 | — | |
| 6-K | 2024-12-16 | — | |
| 6-K | 2024-11-15 | — | |
| 6-K | 2024-09-12 | — | |
| 6-K | 2024-08-16 | — | |
| 6-K | 2024-07-19 | — | |
| 6-K | 2024-07-08 | — | |
| 6-K | 2024-06-27 | — | |
| 6-K | 2024-06-27 | — |
Showing 1–50 of 71 filings